Sentences with phrase «for pharmaceutical and biotechnology»

Austin is also emerging as a hub for pharmaceutical and biotechnology companies.

She is CEO of PsychoGenics Inc., a profitable preclinical CNS service company, CEO of PGI Drug Discovery LLC, a company engaged in psychiatric drug discovery with three partnered Phase II clinical programs and Adjunct Associate Professor of Neuroscience at Mount Sinai School of Medicine, Dr. Leahy has more than 25 years of experience in drug discovery, clinical develop and business development for pharmaceutical and biotechnology companies, including extensive knowledge of technology assessment, licensing, mergers and acquisitions, and strategic planning.

Extended postdoc training and prior industrial experience — absolute musts for pharmaceutical and biotechnology jobs — may not be necessary for entry - level MD&D jobs.

Most carried out no development,» says Barry O'Dowd, IDA Ireland's manager for pharmaceuticals and biotechnology.

Not exact matches

To better measure the success of the companies on Inc.'s 2017 Founders 10 list, EY studied median benchmarks for the biotechnology, life sciences, pharmaceutical, and technology sectors at the time of their IPOs and one, two, and three years later.

With almost 200 stocks in its portfolio, the iShares ETF claims about 80 % of its assets are invested in biotechnology specifically, with the remaining 20 % split between pharmaceutical companies and businesses specializing in tools and services for the life sciences industry.

Pharmabiz Group's first product and widely known website Pharmabiz.com was launched on May 22, 2000 which was followed by the launch of Chronicle Pharmabiz, a weekly publication for the pharmaceutical, biotechnology and healthcare sectors.

GEA is a leading provider of process technology and packaging solutions for the pharmaceutical, biopharmaceutical, biotechnology and nutraceutical industries.

The requirements of pharmaceutical biotechnology sector are extensive — compact design, clear arrangement of the line for aseptic process management, closed product handling, easy access for certified cleaning and low maintenance, reliable compliance with GMP requirements, gentle product treatment, efficient recovery of active ingredients, homogeneity, and reliable scale - up.

Vornado Realty Trust and the Related Companies are targeting biotechnology and pharmaceutical tenants for their redevelopment of the Farley Post Office Building.

A recent search on DirectEmployers.com, a portal to the job posting boards of a consortium of companies, yielded 17 postdoc opportunities posted for 10 highly regarded pharmaceutical and biotechnology companies.

Pharmaceuticals and biotechnology companies often have a person responsible for university recruiting.

Other sources include local biotechnology centers (many larger cities and / or universities have a biotech center for tech transfer or for starting «seed» companies) and larger biotech or pharmaceutical companies in the local area (try the Human Resources department!).

Then there are SMEs that develop biotechnologies, and others that act as middlemen, developing projects spun out from universities, for example, before selling them on to the pharmaceutical industry.

Coming from Georgiou's lab also helped him, he thinks, because Georgiou's work is known for having a strong therapeutic bent: With 29 issued patents, more than half licensed to pharmaceutical and biotechnology companies, Georgiou has close ties with industry.

For the first time in its six years of existence, Science's survey of Top Employers in the biotechnology, biopharmaceutical, pharmaceutical, and related industries has produced a winner not named Genentech.

«These degrees would prepare you for jobs that are pretty well available in biotechnology and pharmaceutical companies,» he says.

Nevertheless, in light of the fierce competition and a slumping market for life sciences jobs in academia, biotechnology, and the pharmaceutical industry, it may be worth considering a career in the MD&D industry.

In recent years, escalating costs and increased global competition have led pharmaceutical and biotechnology companies to start using contractors — temporary employees who work for a contracted period of time — in jobs previously held by permanent employees.

Other top pharmaceutical and biotechnology companies — including Genentech, Amgen, Pfizer, and Merck — also have an ongoing need for pharmacometric skills to optimize drug efficacy and minimize potential toxicities.

Policy planners have always understood that the profit margins in biomedicine are significant, but an added attraction is that the enabling knowledge - based infrastructures for biotechnology and pharmaceuticals, unlike electronic chip manufacturing and even some logistics, can not be easily transplanted in its totality to a cheaper offshore location.

«There is a real gap for project managers in the marketplace, and it is expected that there will be a huge demand for project managers in the larger pharmaceutical and biotechnology industries in the near future,» says Kathryn Pottruff, president of Micro Education Group Inc., a company specializing in strategic planning, project management, and consulting.

The manufacturing output for the industry — which comprises pharmaceutical, medical technology, biotechnology, and health care service companies — grew by 3.2 % to a total of SG$ 6.6 billion in the year 2001.

Despite some recent industry consolidation, the pharmaceutical and biotechnology industries are poised for continued growth and represent good employment options for scientific and medical personnel.

Among the interesting topics covered in Pathways are: the changing role of the patient in the total health equation and the ways in which decentralized information is affecting their expectations and demands; the dearth of pipeline products among international pharmaceutical companies against a backdrop of increased research and development spending; the dynamics of emerging markets and their rising demand for therapies in chronic disease; the value of drugs and biotechnology solutions within the context of global economic realities.

Now a $ 60 billion market for the biotechnology and pharmaceutical sectors, growth of the market has been hampered by high development costs of producing these in animal cell systems, which when factoring in a long period for manufacturing, R&D and clinical trials, may reach around $ 1 billion per each therapeutic candidate.

Thanks to a personal connection, one of the most successful biotechnology companies in the United States is apparently the new title sponsor of the Science Talent Search (STS), the prestigious high school science competitions run by the Society for Science and the Public (SSP) in Washington, D.C. New York - based Regeneron Pharmaceuticals Inc. will invest $ 100 million over the next 10 years to become the third such sponsor in STS's nearly 75 - year - long history, according to several media outlets.

Today, scientists targeting industry can choose from a variety of specialized training courses, which can make a big difference in their «marketability» for jobs at biotechnology, pharmaceutical, medical device, and other firms offering scientific employment opportunities.

PsychoGenics leverages its sophisticated Cube technology platforms and broad capabilities to partner with pharmaceutical, biotechnology and not - for - profit research entities to screen diverse compound libraries and discover valuable new therapies for the CNS market.

In addition, the TNC is a valuable collaborator for biotechnology, pharmaceutical and medical device companies at every stage of research and development.

PsychoGenics works with pharmaceutical and biotechnology companies, academic institutions and not - for - profit research foundations to address such major neurological disorders as: ALS, Huntington's Disease, anxiety, cognitive impairment, depression, psychosis / schizophrenia and SMA.

She joins Moderna after nearly 20 years working with and for leading biotechnology and pharmaceutical companies.

BTT graduates have been placed for training and jobs in a variety of academic research settings and at biomedical, biotechnology, and pharmaceutical companies in the Philadelphia region such as:

The same advantages that drive our pharmaceutical opportunities also apply to our non-pharmaceutical products, which include topical ingredients that are delivering innovation and value for personal care producers, nutritional oils (omega fatty acids) for use in a variety of consumer goods, and applications for agricultural biotechnology.

Specifically, Andrew Baum is a member of the Executive Committee Board of BIO (Biotechnology Industry Organization) serving as vice chair and secretary, is chair of BIO's Food and Agriculture Governing Body, serves as a member and past chair of the BIO working group on plant - made pharmaceuticals and is a member of the Council for Biotechnology Information.

For over 30 years, GE's Life Sciences business has provided tools and technologies to help biotechnology and pharmaceutical companies manufacture biologics.

Change, Exchange, and Rearrange: Protein Engineering for the Biotechnological Production of Fuels, Pharmaceuticals, and Other Chemicals, Fisher, MA, Tullman - Ercek D, Current Opinions in Biotechnology, 24 (6): 1010 - 6.

Esko is collaborating with Zacharon Pharmaceuticals, a San Diego - based biotechnology company, to develop a commercial diagnostic assay for differentiating forms of MPS from urine and blood samples, a screening test for newborns and a tool for measuring the biochemical response of MPS patients to existing and novel therapies.

Increased understanding of the developing brain and how deviations from normal development can increase the risk of neurological and psychiatric diseases has created a rich landscape of opportunity for collaborations between leading academic medical centers and pharmaceutical and biotechnology companies dedicated to identifying new drugs and other interventions to help children.

But while insurers stand to save plenty of money if less women got lymphedema after breast cancer, unlike when new cancer drugs hit the market, exercise offers no immediate profit prospects for pharmaceutical or biotechnology companies — and no multi-million dollar advertising campaign advising patients to query their doctors about it.

James Coon is the Chief Executive Officer of Emulate and has been in the biotechnology and pharmaceutical industry for over 20 years.

Biotechnology firms Biogen and Ionis Pharmaceuticals cut short a phase - 3 clinical trial for the investigational drug nusinersen as it met endpoint...

The hands - on laboratory experience with this industry - standard equipment will also give URI students a competitive advantage in applying for jobs in the growing biotechnology and pharmaceutical industries.The proposal was submitted by: Alan Rothman and Carey Medin of the Institute for Immunology and Informatics and Department of Cell and Molecular Biology; Greg Paquette, Department of Cell and Molecular Biology and URI Biotechnology Center; and Christina Befumo, URI Biotechnology Cbiotechnology and pharmaceutical industries.The proposal was submitted by: Alan Rothman and Carey Medin of the Institute for Immunology and Informatics and Department of Cell and Molecular Biology; Greg Paquette, Department of Cell and Molecular Biology and URI Biotechnology Center; and Christina Befumo, URI Biotechnology CBiotechnology Center; and Christina Befumo, URI Biotechnology CBiotechnology Center.»

GENYO is the first national centre devoted to genomics that integrates the Public Administration, the University and the biotechnology and pharmaceutical business sector, which would allow the integration of research in all its phases, from the generation of knowledge to its development in clinical and pharmaceutical applications, the development of new projects and services for the prevention, diagnosis and treatment of diseases associated to human genetic variability, such a cancer and rare diseases, diabetes, hypertension or degenerative diseases, among others.

Prior to joining Qurr, Dr. Padliya worked closely with the North American salesforce at AB SCIEX to perform several winning demonstrations of accurate high - resolution mass spectrometers that paved the way for new business opportunities with major pharmaceutical and biotechnology accounts.

For the period May 1, 1969 to April 30, 2011, I examine U.S. companies, excluding AMEX companies, high business risk companies, such as Software & Services, Semiconductors & Semiconductor Equipment, Transportation, Automobiles & Components, Real Estate / Construction Materials (GICS 1510) and Pharmaceuticals, Biotechnology & Life Sciences Capital Goods, and companies that had reported extraordinary items the year before.

He has also served as Director for Cancer Immunology and Immunotherapy for the Donald Monk Cancer Research Foundation; he is a partner at Veterinary Research Associates, LLC, a company focused on development and implementation of diagnostics for veterinary medicine and a founder / scientist at ApopLogic Pharmaceuticals, Inc, a biotechnology company focused on development of cancer therapeutics.

Working in partnership with pet owners and their veterinarians, Animal Clinical Investigation (ACI) bridges the veterinary community with pharmaceutical and biotechnology companies to develop novel treatments for pets with cancer and other complex medical conditions.

But while his fans play up his association with the environmental group, they fail to mention his much stronger ties to fossil fuel - intensive industries: For over 20 years, he's been a paid spokesman for companies involved in «mining, energy, forestry, aquaculture, biotechnology, pharmaceuticals and manufacturing.&raqFor over 20 years, he's been a paid spokesman for companies involved in «mining, energy, forestry, aquaculture, biotechnology, pharmaceuticals and manufacturing.&raqfor companies involved in «mining, energy, forestry, aquaculture, biotechnology, pharmaceuticals and manufacturing.»

He handles intellectual property matters for clients in a range of industry sectors including medical devices, biotechnology, pharmaceuticals, software, and signal and imaging processing.